Micro Agrochemicals
Market Cap
₹1,758 ₹1,758 Cr.
P/E
14.05
PEG
1.24
PEG = P/E ÷ 5yr Forward EPS CAGR
5yr Forward EPS CAGR Thesis - Base Case

- The thesis comes alive if premium-product adoption, better capacity use and Sotanala commissioning translate into stronger B2C and B2B growth with margin improvement.- The bull path depends on earlier commissioning and faster premiumization, while delayed commissioning, weak premium mix, export slippage and pricing pressure drive the bear case.

Key Ratios

Debt to Equity
Debt to Equity
0.12
Div Yield (%)
Div Yield (%)
0.33
Individual < 2 lac
Individual < 2 lac
9.23 %
Institutions
Institutions
13.64 %
Market cap
Market cap
1,758 Cr
No. of Shareholders
No. of Shareholders
21,380
OPM (%)
OPM (%)
10.20 %
PE
PE
14.05
Prom Holding
Prom Holding
72.30 %
ROCE (%)
ROCE (%)
15.59
ROE (%)
ROE (%)
11.42
Sales
Sales
2,060 Cr
  • Insecticides India
  • Bharat Rasayan
  • Meghmani Organics
  • TJI Chemicals
Last updated on 17 Aug 2026
  • Insecticides India makes crop-protection chemicals, insecticides, herbicides, fungicides; B2C 73%, B2B 22%, exports 5%; shifted to premium mix after FY23 price collapse.
  • Q1FY27 revenue fell ~12% on delayed monsoon demand; gross margin held at 31.6% but PAT fell 24.5%.
  • Earnings ride B2C premium mix, ~62–64% latest quarter with new launches scaling; rising B2B share adds volatility.
  • Per management, integrated platform with own R&D, tech partnerships and technical manufacturing cuts single-crop dependence.
  • Building technical and international mix; Sotanala ₹200Cr underway; focus on utilization, cash and ROCE; capex seen at ~₹30–40Cr.
  • Working capital elevated at 168 days; high receivables and inventory constrain cash conversion.
  • Kharif execution decides near term; management aims for 70% premium in 3–4 years and doubling in 4–5.
  • Deferred-demand Q2 print ~mid-Nov 2026
    shows if delayed kharif demand rebounds and returns halve from last year.
  • New launches scale-up Q2–Q4 FY27
    Granuvia ~₹20Cr and Spinoace >₹10Cr gross, ~₹25Cr net combined, repeat buying decides scale.
  • Working-capital path FY27
    moves toward 120 days from 168-day FY26 base on receivables and inventory turns.
  • KAEROS scale-up FY27 and medium term
    40+ products live; 100% then 50–60% growth targets show B2B scale.
  • Sotanala formulation Apr–May 2027 (was Diwali 2026)
    first formulation capacity online; ₹50Cr part, ~₹70Cr already invested.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
519
52W Range
High
789
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

11 Yes

Positive for this company

1 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

7 %
(as of Mar 18)
Pestcide & Insecticide Segment Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Location Wise Break-Up - India

Distribution Channel

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on Insecticides (India) Ltd. Business

Insecticides (India) Ltd, established in 1996 and headquartered in Delhi, is a public limited company engaged in manufacturing Agro Chemicals and Pesticides for domestic and international markets.

Insecticides India major competitors are Bharat Rasayan, Astec Lifesciences, Meghmani Organics, India Pesticides, Punjab Chem. & Corp., Excel Industries, Dharmaj Crop Guard.
Market Cap of Insecticides India is ₹1,756 Crs.
While the median market cap of its peers are ₹1,543 Crs.

Insecticides India seems to be less financially stable compared to its competitors.
Altman Z score of Insecticides India is 3.66 and is ranked 6 out of its 8 competitors.

Company Filing

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material